Abplatin(IV) inhibited tumor growth on a patient derived cancer model of hepatocellular carcinoma and its comparative multi-omics study with cisplatin
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Abplatin(IV) inhibited tumor growth on a patient derived cancer model of hepatocellular carcinoma and its comparative multi-omics study with cisplatin
Authors
Keywords
-
Journal
JOURNAL OF NANOBIOTECHNOLOGY
Volume 20, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2022-06-03
DOI
10.1186/s12951-022-01465-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Near-Infrared-II Polymer with Tandem Fluorophores Demonstrates Superior Biodegradability for Simultaneous Drug Tracking and Treatment Efficacy Feedback
- (2021) Dengshuai Wei et al. ACS Nano
- Nanoparticle-mediated convection-enhanced delivery of a DNA intercalator to gliomas circumvents temozolomide resistance
- (2021) Yongheng Wang et al. Nature Biomedical Engineering
- Albumin Nanoparticle of Paclitaxel (Abraxane) Decreases while Taxol Increases Breast Cancer Stem Cells in Treatment of Triple Negative Breast Cancer
- (2020) Hebao Yuan et al. MOLECULAR PHARMACEUTICS
- Breaking the Intracellular Redox Balance with Diselenium Nanoparticles for Maximizing Chemotherapy Efficacy on Patient-Derived Xenograft Models
- (2020) Dengshuai Wei et al. ACS Nano
- PTEN Methylation by NSD2 Controls Cellular Sensitivity to DNA Damage
- (2019) Jinfang Zhang et al. Cancer Discovery
- Advances in Toxicological Research of the Anticancer Drug Cisplatin
- (2019) Luyu Qi et al. CHEMICAL RESEARCH IN TOXICOLOGY
- Arginine: Challenges and opportunities of this two-faced molecule in cancer therapy
- (2018) Mozhgan Jahani et al. BIOMEDICINE & PHARMACOTHERAPY
- Platinum(iv) prodrugs with long lipid chains for drug delivery and overcoming cisplatin resistance
- (2018) Qiling Chen et al. CHEMICAL COMMUNICATIONS
- The side effects of platinum-based chemotherapy drugs: a review for chemists
- (2018) Rabbab Oun et al. DALTON TRANSACTIONS
- Polymer therapeutics and the EPR effect
- (2017) Hiroshi Maeda JOURNAL OF DRUG TARGETING
- l-Carnitine and Acetyl-l-carnitine Roles and Neuroprotection in Developing Brain
- (2017) Gustavo C. Ferreira et al. NEUROCHEMICAL RESEARCH
- The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
- (2016) Timothy C. Johnstone et al. CHEMICAL REVIEWS
- Platinum(iv) anticancer prodrugs – hypotheses and facts
- (2016) Dan Gibson DALTON TRANSACTIONS
- Design, synthesis and biological evaluation of a novel series of glycosylated platinum(iv) complexes as antitumor agents
- (2016) Qingpeng Wang et al. DALTON TRANSACTIONS
- Glycosylated platinum(iv) prodrugs demonstrated significant therapeutic efficacy in cancer cells and minimized side-effects
- (2016) Jing Ma et al. DALTON TRANSACTIONS
- CLDN6-induced apoptosis via regulating ASK1-p38/JNK signaling in breast cancer MCF-7 cells
- (2016) YAXIONG GUO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Multi-Omics of Single Cells: Strategies and Applications
- (2016) Christoph Bock et al. TRENDS IN BIOTECHNOLOGY
- Conjugation of Cisplatin Analogues and Cyclooxygenase Inhibitors to Overcome Cisplatin Resistance
- (2014) Wilma Neumann et al. ChemMedChem
- Xanthosine administration does not affect the proportion of epithelial stem cells in bovine mammary tissue, but has a latent negative effect on cell proliferation
- (2014) Gat Rauner et al. EXPERIMENTAL CELL RESEARCH
- nab-Paclitaxel mechanisms of action and delivery
- (2013) Denise A. Yardley JOURNAL OF CONTROLLED RELEASE
- Impact of albumin on drug delivery — New applications on the horizon
- (2011) Bakheet Elsadek et al. JOURNAL OF CONTROLLED RELEASE
- Molecular mechanisms of cisplatin resistance
- (2011) L Galluzzi et al. ONCOGENE
- Bioorganometallic chemistry—from teaching paradigms to medicinal applications
- (2008) Christian G. Hartinger et al. CHEMICAL SOCIETY REVIEWS
- Regulation and Pathological Role of p53 in Cisplatin Nephrotoxicity
- (2008) M. Jiang et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search